{"title": "mRNA vaccines take the sting out of malaria infection\u2014and transmission", "author": "Helen Floersh", "url": "https://www.fiercebiotech.com/research/mrna-malaria-vaccines-target-infection-and-transmission", "hostname": "fiercebiotech.com", "description": "After nearly four decades of development, the world finally has a malaria vaccine. The first large-scale rollout of GlaxoSmithKline's RTS,S, or Mosquirix, kicked off at the end of November. | A research team used mRNA to build a two-part vaccine set that both prevents infection and stops the cycle of malaria transmission between people and mosquitoes.", "sitename": "FierceBiotech", "date": "2022-12-01", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}